Navigation Links
BioMS Medical Announces 2009 Year End Results
Date:3/16/2010

(1,343) ------------ ------------ Foreign exchange gain (loss) on cash and cash equivalents held in foreign currency (134) 3,698 ------------ ------------ (Decrease) increase in cash and cash equivalents (39,052) 52,398 Cash and cash equivalents - Beginning of year 87,826 35,428 ------------ ------------ Cash and cash equivalents - End of year 48,774 87,826 ------------ ------------ ------------ ------------ Cash and cash equivalents consists of Bank accounts 14,855 610 Interest bearing deposits and securities 33,919 87,216 ------------ ------------ 48,774 87,826 ------------ ------------ ------------ ------------

SOURCE BioMS Medical Corp.

Back to top
'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. BioMS Medical reports Spectral receives FDA approval to initiate pivotal trial and closes financing for $19.5 million
2. Spectral diagnostics Raises $14 million and enters into strategic collaboration with BioMS Medical to commercialize treatment for sepsis
3. BioMS Medical provides corporate update
4. BioMS Medical Announces Third Quarter 2009 Results
5. BioMS Medical announces second quarter 2009 results
6. BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences
7. BioMS Medical to participate in panel session at Bio International Convention 2009
8. BioMS Medical Announces First quarter 2009 results
9. BioMS Medical to present at Alberta Economic Forum in Geneva
10. BioMS Medical to present at BioFinance 2009
11. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2015)... Research and Markets( ... "Global Cancer Biosimilars Market Opportunity Outlook" ... of cancer biosimilar is required because they have ... have dominated the cancer segment for several decade ... past few years. They are biologic in origin ...
(Date:6/25/2015)... , June 25, 2015 Last June, a ... to track the virus using large-scale genome sequencing. Their research, ... June 18 in the journal Cell (Park ... and mutated over seven months of the recent Ebola outbreak. ... working draft, data, workflows, and full edit history of ...
(Date:6/25/2015)... ... June 25, 2015 , ... ... University will enjoy (8) new chemistry laboratories, each exclusively using filtered fume hoods ... team finished installing the (49) filtered fume hoods needed for their Organic, Inorganic, ...
(Date:6/25/2015)... , June 25, 2015 ... to co-invest with Startup Nation,s leading angels and gain ... of Darya Fuks as Portfolio Manager.  , ... Bank, will lead iAngels, deal flow and due diligence ... efforts for all iAngels portfolio companies. An investment banker ...
Breaking Biology Technology:Global Cancer Biosimilars Market Opportunity Outlook 2Global Cancer Biosimilars Market Opportunity Outlook 3Open Science Takes Major Leap Forward 2This Summer Erlab Completes the Largest Installation of Filtered Fume Hoods in the World 2Former J.P. Morgan Vice President Darya Fuks Joins iAngels 2Former J.P. Morgan Vice President Darya Fuks Joins iAngels 3
... 6 /Xinhua-PRNewswire-FirstCall/ -- Shengtai,Pharmaceutical, Inc. (OTC Bulletin ... leading manufacturer and distributor,of high-quality, pharmaceutical grade ... products that serve as raw materials for ... it will conduct a conference,call at 9:00 ...
... Expands the Company,s Clinical Stage Product Portfolio ... Meditrina Pharmaceuticals,Inc. today announced that it ... make, develop and commercialize products under AstraZeneca,s ... inhibitors (AI) in combination with,estrogen and progestin ...
... Inc. ("Senesco" or the "Company") (Amex: SNT ... focused on multiple myeloma that,were conducted concurrently at ... of these studies, which utilized two different dosing ... Factor 5A technology to induce,apoptosis in tumors. Additionally, ...
Cached Biology Technology:Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008 2Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008 3Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca 2Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca 3Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies 2Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies 3
(Date:6/12/2015)... 2015  Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring, announced the United ... capture, analyze and identify participants of a video ... This system can: , Identify ... subsequent sign-on process is actually the person participating ...
(Date:6/9/2015)... Minn. , June 9, 2015   MedNet ... supports the entire spectrum of clinical research, will be ... eClinical technology platform at the 2015 Drug Information Association ... on June 15-17.  These presentations will include previews ... rolled out in the upcoming iMedNet 2015 ...
(Date:6/8/2015)... June 8, 2015  The Secure Identity ... selection of Troy Potter of L-3 ... SIBA is a non-profit association that was established ... education and implementation of solutions that protect and ... ...
Breaking Biology News(10 mins):Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 2Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 3Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 4Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 5
... VANCOUVER, BRITISH COLUMBIA Parents of children with chronic ... to a study being presented Monday, May 3 at ... British Columbia, Canada. Medication use in children with ... been done on mistakes made by parents giving these ...
... in complex networks that govern cellular processes, much like people ... discovering how biological networks change and are rewired in cancer. ... ( www.genome.org ), scientists have analyzed the genetic networks ... awry in disease. MicroRNAs (miRNAs) are short RNA molecules ...
... , STANFORD, Calif. - Life is almost unbearably complex. ... and off in dizzying combinations and sequences during their ... to understand the machinations of the proteins behind the ... their disposal, courtesy of researchers at the Stanford University ...
Cached Biology News:Home medication errors common among children with chronic conditions 2MicroRNA network study implicates rewired interactions in cancer 2New Stanford tool enables wider analyses of genome 'deep sequencing' 2New Stanford tool enables wider analyses of genome 'deep sequencing' 3
...
...
D.R. Harper and C. Grose (1994) • Includes: virus structure & replication, fundamental virology, immunology and pathogenesis, vaccines and antiviral drugs, novel diagnostic techniques, cloning a...
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
Biology Products: